Free Trial

Sage Therapeutics (SAGE) SEC Filings & 10K Form

Sage Therapeutics logo
$9.11 -0.03 (-0.33%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$9.11 0.00 (0.00%)
As of 07/18/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sage Therapeutics SEC Filings

DateFilerForm TypeView
07/02/2025
4:21 PM
Sage Therapeutics (Subject)
Form SC 14D9
06/26/2025
3:02 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:20 PM
Sage Therapeutics (Subject)
Form SC14D9C
06/16/2025
4:26 PM
Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
Form SC TO-C
06/16/2025
10:40 AM
Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
Form SC TO-C
06/16/2025
6:55 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2025
3:15 PM
Sage Therapeutics (Filer)
Form DEF 14A
04/24/2025
3:20 PM
Sage Therapeutics (Filer)
Form DEFA14A
04/24/2025
3:25 PM
Sage Therapeutics (Filer)
Form ARS
04/01/2025
4:35 PM
Madison Avenue Partners, LP (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G
03/26/2025
3:36 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
9:01 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G/A
03/04/2025
3:45 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:30 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G/A
02/11/2025
4:16 PM
Sage Therapeutics (Filer)
Form POS AM
02/05/2025
9:41 AM
MORGAN STANLEY (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G
01/31/2025
8:55 AM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/27/2025
8:28 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
5:02 AM
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
5:06 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:34 PM
BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
Form SCHEDULE 13D
12/27/2024
3:11 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:47 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:42 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:40 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:14 PM
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:56 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/04/2024
2:28 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:23 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:24 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:20 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
10:37 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/17/2024
6:11 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
5:37 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
6:07 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:33 AM
Sage Therapeutics (Filer)
Form S-3ASR
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
07/31/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:15 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
5:39 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SAGE) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners